Minor Adverse Events Postcolonoscopy

Minor Adverse Events Postcolonoscopy

Saved in:

Bibliographic Details
Main Author:	Catherine Dubé
Format:	Article
Language:	English
Published:	Wiley 2014-01-01
Series:	Canadian Journal of Gastroenterology and Hepatology
Online Access:	http://dx.doi.org/10.1155/2014/128289
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Acute Pancreatitis and Ileus Postcolonoscopy
by: Hin Hin Ko, et al.
Published: (2009-01-01)

Safety of creatine supplementation: Analysis of Adverse Events reported in clinical trials and adverse event reports
by: Sarah E. Johnson, et al.
Published: (2025-09-01)

Analysis of postmarketing neuropsychiatric adverse events of avapritinib based on the FDA adverse event reporting system
by: Wei Mao, et al.
Published: (2025-01-01)

Comprehensive analysis of adverse events associated with vortioxetine using the FDA adverse event reporting system
by: Liangxia Li, et al.
Published: (2025-05-01)

Adverse events associated with amlodipine: a pharmacovigilance study using the FDA adverse event reporting system
by: Jiazhen Jiang, et al.
Published: (2025-05-01)

Musculoskeletal adverse events reported post-hepatitis B vaccination in the vaccine adverse event reporting system
by: Yiqing Sun, et al.
Published: (2025-05-01)

Adverse events associated with gepants: a pharmacovigilance analysis based on the FDA adverse event reporting system
by: Qi Song, et al.
Published: (2025-06-01)

Three aspects of acupuncture-related adverse events: Issues around the reporting of acupuncture-related adverse events
by: Tae-Hun Kim, et al.
Published: (2023-09-01)

What to do in the event of an adverse anaesthetic event or medical error
by: Jenny Thomas
Published: (2014-05-01)

Exploring Novel Adverse Events of Nefecon
by: Jingyu Wang, et al.
Published: (2024-09-01)

Neurologic adverse events of cancer immunotherapy
by: Marcelo Houat de Brito
Published: (2022-08-01)

An infrequent but unpleasant adverse event of Tamsulosin
by: Antonio Villa
Published: (2024-04-01)

Correction: Adverse events associated with amlodipine: a pharmacovigilance study using the FDA adverse event reporting system
by: Jiazhen Jiang, et al.
Published: (2025-06-01)

Neurological adverse events associated with baclofen: A disproportionality analysis based on FDA Adverse Event Reporting System
by: Ni Zhang, et al.
Published: (2025-04-01)

Exploration of adverse event profiles for cefotaxime: a disproportionality analysis using the FDA adverse event reporting system
by: Cheng Jiang, et al.
Published: (2025-07-01)

Adverse event profile differences between maribavir and valganciclovir: findings from the FDA adverse event reporting system
by: Haolin Teng, et al.
Published: (2025-05-01)

Neurological adverse events associated with baclofen: a pharmacovigilance study based on FDA adverse event reporting system
by: Yunhan Zhao, et al.
Published: (2025-05-01)

Postmarketing Surveillance of Full Spectrum Hemp Extract CBD Products: Reported Adverse Events and Serious Adverse Events
by: Colleen M. Kingsbury, et al.
Published: (2024-09-01)

Ophthalmic corticosteroids-related adverse events: the FDA adverse event reporting system (FAERS) database pharmacovigilance study
by: Chengzhi Liu, et al.
Published: (2024-12-01)

Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database
by: Chang-Zhu He, et al.
Published: (2025-03-01)

Factors associated with adverse events following immunization in Albanian children: An analysis of the national database of adverse events after immunization
by: Irsida Mehmeti, et al.
Published: (2019-03-01)

Safety assessment of laronidase: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS)
by: Zhuomiao Lin, et al.
Published: (2025-08-01)

Neurological adverse events associated with antidepressants: a comprehensive 22-year analysis of the FDA adverse event reporting system
by: Qian Yu, et al.
Published: (2025-08-01)

Disproportionality analysis of upadacitinib-related adverse events in inflammatory bowel disease using the FDA adverse event reporting system
by: Shiyi Wang, et al.
Published: (2025-02-01)

Adverse events associated with herbal medicine products reported in the Korea Adverse Event Reporting System from 2012 to 2021
by: Yujin Choi, et al.
Published: (2024-10-01)

Evaluation of post-market adverse events of lubiprostone: a real-world adverse event analysis from the FAERS database
by: Qingqing Li, et al.
Published: (2025-05-01)

Immune Checkpoint Inhibitors and Cardiovascular Adverse Events
by: Maria Luisa De Perna, et al.
Published: (2025-08-01)

Incidents and adverse events notified at hospital level
by: Andréia Mascarello, et al.
Published: (2021-01-01)

Incidents and adverse events notified at hospital level
by: Andréia Mascarello, et al.
Published: (2021-01-01)

Contribution of adverse events to death of hospitalised patients
by: Ellinor Christin Haukland, et al.
Published: (2019-01-01)

Rare Adverse Events of CAR T-Cell Therapy
by: Antonia Müller
Published: (2024-03-01)

Chamomile: A systematic review of adverse events
by: Mohadeseh Ostovar, et al.
Published: (2025-08-01)

Biomarkers of Adverse Cardiovascular Events in Kidney Disease
by: L. A. Kamyshnikova, et al.
Published: (2023-08-01)

Mining and analysis of dizziness adverse event signals in postoperative analgesia patients based on the FDA adverse event reporting system database
by: Fengqi Zhou, et al.
Published: (2025-02-01)

Age-stratified analysis of adverse event signals for clarithromycin: a disproportionality analysis using the FDA Adverse Event Reporting System
by: Haiyan Mai, et al.
Published: (2025-01-01)

Updated insights into adverse events associated with mepolizumab: a disproportionality analysis from the FDA adverse event reporting system database
by: Shan Lin, et al.
Published: (2024-10-01)

Hepatobiliary Adverse Events Associated with Pembrolizumab: A Pharmacovigilance Study from the FDA Adverse Event Reporting System (FAERS) Database
by: Connor Frey
Published: (2024-12-01)

Pharmacovigilance analysis of neurological adverse events associated with GLP-1 receptor agonists based on the FDA Adverse Event Reporting System
by: He Chen, et al.
Published: (2025-05-01)

Analysis of Adverse Events Associated With Dental Local Anaesthetics Using Food and Drug Administration Adverse Event Reporting System Data
by: Ferit Bayram, et al.
Published: (2025-06-01)

Relationship between thromboembolic events and thrombopoietin receptor agonists: a pharmacovigilance analysis of the FDA Adverse Event Reporting System and the Japanese Adverse Drug Event Report
by: Zheng Wang, et al.
Published: (2025-08-01)